Literature DB >> 11703987

In-hospital and long-term prognostic value of viable myocardium detected by dobutamine echocardiography early after acute myocardial infarction and its relation to indicators of left ventricular systolic dysfunction.

F Nijland1, O Kamp, P M Verhorst, W G de Voogt, C A Visser.   

Abstract

The prognostic value of myocardial viability early after acute myocardial infarction (AMI) is still controversial, depending on the patient under study and the outcome end point considered. Furthermore, the relative prognostic importance of viability compared with indicators of systolic left ventricular (LV) dysfunction is not known. One hundred thirty-eight patients were studied with low-dose dobutamine echocardiography 3 +/- 1 days after AMI. Patients were divided in 2 groups based on presence (n = 55) or absence (n = 83) of myocardial viability and followed up for in-hospital and late cardiac events. During hospitalization, myocardial viability was the only independent predictor for recurrent ischemic events (chi-square 5.0, p = 0.025). End-systolic volume index and ejection fraction were both independent predictors of the occurrence of heart failure, whereas gender and end-systolic volume index emerged as independent predictors of hard cardiac events (death and sustained ventricular tachycardia). After hospital discharge, patients were followed for 19 +/- 7 months. Again, myocardial viability emerged as the only independent predictor of unstable angina (chi-square 7.7, p = 0.005). Age, hypertension, and ejection fraction were the most important independent predictors of hospitalization for heart failure, whereas ejection fraction was the only independent predictor of hard cardiac events. Presence of myocardial viability early after AMI is the single best predictor of recurrent in-hospital ischemic events and unstable angina after discharge. With respect to hard cardiac events and occurrence of heart failure, indicators of LV systolic dysfunction have a higher prognostic value than presence of myocardial viability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11703987     DOI: 10.1016/s0002-9149(01)01968-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Myocardial viability assessed by dobutamine stress echocardiography predicts reduced mortality early after acute myocardial infarction: determining the risk of events after myocardial infarction (DREAM) study.

Authors:  J M A Swinburn; R Senior
Journal:  Heart       Date:  2005-04-14       Impact factor: 5.994

2.  Dobutamine stress echocardiography can predict reversible ventricular dysfunction after acute myocardial infarction.

Authors:  Víctor M Mauro; Tomás F Cianciulli; Horacio A Prezioso; Sergio D Llanos Dethinne; Jorge H Leguizamón; Adrían A Charask; Enrique B Fairman; Yanina Castillo Costa; Carlos M Barrero
Journal:  Clin Cardiol       Date:  2005-11       Impact factor: 2.882

3.  Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure.

Authors:  Ali Ahmed; Michael R Zile; Michael W Rich; Jerome L Fleg; Kirkwood F Adams; Thomas E Love; James B Young; Wilbert S Aronow; Dalane W Kitzman; Mihai Gheorghiade; Louis J Dell'Italia
Journal:  Am J Cardiol       Date:  2006-12-21       Impact factor: 2.778

4.  Gender-related dissociation in outcomes in chronic heart failure: reduced mortality but similar hospitalization in women.

Authors:  Mustafa I Ahmed; Mitja Lainscak; Marjan Mujib; Thomas E Love; Inmaculada Aban; Ileana L Piña; Wilbert S Aronow; Vera Bittner; Ali Ahmed
Journal:  Int J Cardiol       Date:  2009-11-24       Impact factor: 4.164

5.  Incident coronary revascularization and subsequent mortality in chronic heart failure: a propensity-matched study.

Authors:  Grigorios Giamouzis; Syed Abbas Agha; O James Ekundayo; Inmaculada Aban; Thomas E Love; Casey Daniel; Javed Butler; Ali Ahmed
Journal:  Int J Cardiol       Date:  2008-12-11       Impact factor: 4.164

6.  Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure.

Authors:  Taimoor Hashim; Shereen Elbaz; Kanan Patel; Charity J Morgan; Gregg C Fonarow; Jerome L Fleg; Gerald McGwin; Gary R Cutter; Richard M Allman; Sumanth D Prabhu; Michael R Zile; Robert C Bourge; Ali Ahmed
Journal:  Am J Med       Date:  2013-09-23       Impact factor: 4.965

7.  Improved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial).

Authors:  Ramon B van Loon; Gerrit Veen; Leo H B Baur; Otto Kamp; Jean G F Bronzwaer; Jos W R Twisk; Freek W A Verheugt; Albert C van Rossum
Journal:  Trials       Date:  2012-01-03       Impact factor: 2.279

8.  Early and long-term outcome of elective stenting of the infarct-related artery in patients with viability in the infarct-area: Rationale and design of the Viability-guided Angioplasty after acute Myocardial Infarction-trial (The VIAMI-trial).

Authors:  Ramon B van Loon; Gerrit Veen; Otto Kamp; Jean Gf Bronzwaer; Cees A Visser; Frans C Visser
Journal:  Curr Control Trials Cardiovasc Med       Date:  2004-11-11

9.  Left ventricular remodeling after acute myocardial infarction: the influence of viability and revascularization - an echocardiographic substudy of the VIAMI-trial.

Authors:  Ramon B van Loon; Gerrit Veen; Otto Kamp; Leo H B Baur; Albert C van Rossum
Journal:  Trials       Date:  2014-08-18       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.